PubMed

Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity.

Kershaw EE, Morton NM, Dhillon H, Ramage L, Seckl JR, Flier JS.

Diabetes. 2005 Apr;54(4):1023-31.PMID: 15793240 [PubMed - indexed for MEDLINE]Related articlesFree article

11beta-hydroxysteroid dehydrogenase type 1 and obesity.

Morton NM, Seckl JR.

Front Horm Res. 2008;36:146-64. Review.PMID: 18230901 [PubMed - indexed for MEDLINE]Related articles

High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance.

Gnudi L, Tozzo E, Shepherd PR, Bliss JL, Kahn BB.

Endocrinology. 1995 Mar;136(3):995-1002.PMID: 7867610 [PubMed - indexed for MEDLINE]Related articles

Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.

Masuzaki H, Flier JS.

Curr Drug Targets Immune Endocr Metabol Disord. 2003 Dec;3(4):255-62. Review.PMID: 14683456 [PubMed - indexed for MEDLINE]Related articles

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice.

Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR.

Diabetes. 2004 Apr;53(4):931-8.PMID: 15047607 [PubMed - indexed for MEDLINE]Related articlesFree article

Adipose tissue expression of 11beta-hydroxysteroid dehydrogenase type 1 in Cushing's syndrome and in obesity.

Espíndola-Antunes D, Kater CE.

Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1397-403.PMID: 18209879 [PubMed - indexed for MEDLINE]Related articlesFree article

A transgenic model of visceral obesity and the metabolic syndrome.

Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS.

Science. 2001 Dec 7;294(5549):2166-70.PMID: 11739957 [PubMed - indexed for MEDLINE]Related articlesFree article

11-Beta hydroxysteroid dehydrogenase type 2 expression in white adipose tissue is strongly correlated with adiposity.

Milagro FI, Campión J, Martínez JA.

J Steroid Biochem Mol Biol. 2007 Apr;104(1-2):81-4. Epub 2007 Jan 8.PMID: 17208436 [PubMed - indexed for MEDLINE]Related articles

Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.

Stimson RH, Walker BR.

Minerva Endocrinol. 2007 Sep;32(3):141-59. Review.PMID: 17912154 [PubMed - indexed for MEDLINE]Related articles

Endurance exercise training increases adipose tissue glucocorticoid exposure: adaptations that facilitate lipolysis.

Campbell JE, Fediuc S, Hawke TJ, Riddell MC.

Metabolism. 2009 May;58(5):651-60.PMID: 19375588 [PubMed - indexed for MEDLINE]Related articles

Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment.

Takasawa K, Kubota N, Terauchi Y, Kadowaki T.

Endocr J. 2008 Aug;55(4):767-76. Epub 2008 May 28.PMID: 18506083 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistance.

Asensio C, Muzzin P, Rohner-Jeanrenaud F.

Int J Obes Relat Metab Disord. 2004 Dec;28 Suppl 4:S45-52. Review.PMID: 15592486 [PubMed - indexed for MEDLINE]Related articles

Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis.

Asensio C, Cettour-Rose P, Theander-Carrillo C, Rohner-Jeanrenaud F, Muzzin P.

Endocrinology. 2004 May;145(5):2206-13. Epub 2004 Feb 12.PMID: 14962997 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue.

Seckl JR, Morton NM, Chapman KE, Walker BR.

Recent Prog Horm Res. 2004;59:359-93. Review.PMID: 14749510 [PubMed - indexed for MEDLINE]Related articlesFree article

Calcium and dairy products inhibit weight and fat regain during ad libitum consumption following energy restriction in Ap2-agouti transgenic mice.

Sun X, Zemel MB.

J Nutr. 2004 Nov;134(11):3054-60.PMID: 15514275 [PubMed - indexed for MEDLINE]Related articlesFree article

The polygenetically inherited metabolic syndrome of WOKW rats is associated with insulin resistance and altered gene expression in adipose tissue.

Klöting N, Blüher M, Klöting I.

Diabetes Metab Res Rev. 2006 Mar-Apr;22(2):146-54.PMID: 16041833 [PubMed - indexed for MEDLINE]Related articles

Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit.

Villena JA, Viollet B, Andreelli F, Kahn A, Vaulont S, Sul HS.

Diabetes. 2004 Sep;53(9):2242-9.PMID: 15331533 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduction of dietary obesity in aP2-Ucp transgenic mice: physiology and adipose tissue distribution.

Kopecký J, Hodný Z, Rossmeisl M, Syrový I, Kozak LP.

Am J Physiol. 1996 May;270(5 Pt 1):E768-75.PMID: 8967464 [PubMed - indexed for MEDLINE]Related articles

Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo.

De Sousa Peixoto RA, Turban S, Battle JH, Chapman KE, Seckl JR, Morton NM.

Endocrinology. 2008 Apr;149(4):1861-8. Epub 2008 Jan 3.PMID: 18174284 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of the fatty acid binding protein mal1 in obesity and insulin resistance.

Maeda K, Uysal KT, Makowski L, Görgün CZ, Atsumi G, Parker RA, Brüning J, Hertzel AV, Bernlohr DA, Hotamisligil GS.

Diabetes. 2003 Feb;52(2):300-7.PMID: 12540600 [PubMed - indexed for MEDLINE]Related articlesFree article